Upgrade to SI Premium - Free Trial

Zimmer Biomet (ZBH) PT Raised to $155 at Stifel After Orthopedic Procedures Rebound

August 5, 2020 6:29 AM
Stifel analyst Rick Wise raised the price target on Zimmer Biomet (NYSE: ZBH) to $155.00 (from $130.00) after 2Q20 results ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst EPS Change Analyst EPS View Analyst PT Change

Next Articles